Companies included in IBB Page 2
This is IBB's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 101–200 of 258.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| VCEL | Vericel Corp. | 373,502 | NS | 0.147926% |
| MLYS | Mineralys Therapeutics, Inc. | 439,648 | NS | 0.146628% |
| ALMS | Alumis, Inc. | 530,358 | NS | 0.143842% |
| ZLAB | Zai Lab Ltd. | 613,747 | NS | 0.142128% |
| NRIX | Nurix Therapeutics, Inc. | 720,848 | NS | 0.137555% |
| STOK | Stoke Therapeutics, Inc. | 331,288 | NS | 0.132798% |
| NTLA | Intellia Therapeutics, Inc. | 835,337 | NS | 0.131841% |
| ANAB | AnaptysBio, Inc. | 192,136 | NS | 0.131187% |
| RXRX | Recursion Pharmaceuticals, Inc. | 3,419,857 | NS | 0.129255% |
| TYRA | Tyra Biosciences, Inc. | 272,474 | NS | 0.128477% |
| RLAY | Relay Therapeutics, Inc. | 980,266 | NS | 0.120079% |
| AMLX | Amylyx Pharmaceuticals, Inc. | 687,536 | NS | 0.117655% |
| NVAX | Novavax, Inc. | 1,157,114 | NS | 0.115958% |
| IOVA | Iovance Biotherapeutics, Inc. | 2,619,021 | NS | 0.113174% |
| WVE | WaVe Life Sciences Ltd. | 1,176,186 | NS | 0.104982% |
| IMCR | Immunocore Holdings plc | 277,185 | NS | 0.102887% |
| NVCR | Novocure Ltd. | 763,201 | NS | 0.102416% |
| Galapagos NV | Galapagos NV | 271,893 | NS | 0.10042% |
| Grifols SA | Grifols SA | 976,161 | NS | 0.096382% |
| BHVN | Biohaven Ltd. | 917,535 | NS | 0.095564% |
| NUVB | Nuvation Bio, Inc. | 1,795,888 | NS | 0.09485% |
| ATAI | AtaiBeckley, Inc. | 2,160,067 | NS | 0.09414% |
| TSHA | Taysha Gene Therapies, Inc. | 1,672,180 | NS | 0.092022% |
| SION | Sionna Therapeutics, Inc. | 185,101 | NS | 0.091358% |
| TRVI | Trevi Therapeutics, Inc. | 608,481 | NS | 0.089369% |
| Mesoblast Ltd. | Mesoblast Ltd. | 460,143 | NS | 0.087127% |
| CRVS | Corvus Pharmaceuticals, Inc. | 473,326 | NS | 0.085252% |
| OLMA | Olema Pharmaceuticals, Inc. | 457,751 | NS | 0.084025% |
| RAPP | Rapport Therapeutics, Inc. | 217,759 | NS | 0.083885% |
| QURE | uniQure NV | 413,699 | NS | 0.083273% |
| GERN | Geron Corp. | 4,513,103 | NS | 0.082787% |
| FTRE | Fortrea Holdings, Inc. | 693,057 | NS | 0.080375% |
| VIR | Vir Biotechnology, Inc. | 704,449 | NS | 0.077707% |
| XNCR | Xencor, Inc. | 513,267 | NS | 0.076207% |
| ABCL | AbCellera Biologics, Inc. | 1,732,022 | NS | 0.074418% |
| MBX | MBX Biosciences, Inc. | 199,599 | NS | 0.073351% |
| MAZE | Maze Therapeutics, Inc. | 197,936 | NS | 0.07274% |
| CDNA | CareDx, Inc. | 337,886 | NS | 0.072214% |
| TBPH | Theravance Biopharma, Inc. | 353,652 | NS | 0.070664% |
| GLUE | Monte Rosa Therapeutics, Inc. | 346,430 | NS | 0.070159% |
| KalVista Pharmaceuticals, Inc. | KalVista Pharmaceuticals, Inc. | 276,916 | NS | 0.068627% |
| JANX | Janux Therapeutics, Inc. | 392,349 | NS | 0.067141% |
| PHVS | Pharvaris NV | 191,961 | NS | 0.066763% |
| MNKD | MannKind Corp. | 2,199,381 | NS | 0.066339% |
| ORIC | ORIC Pharmaceuticals, Inc. | 424,422 | NS | 0.066203% |
| CSTL | Castle Biosciences, Inc. | 215,689 | NS | 0.06519% |
| ANNX | Annexon, Inc. | 952,884 | NS | 0.064991% |
| URGN | UroGen Pharma Ltd. | 286,041 | NS | 0.063317% |
| KURA | Kura Oncology, Inc. | 628,449 | NS | 0.062902% |
| INBX | Inhibrx Biosciences, Inc. | 75,835 | NS | 0.062767% |
| Stevanato Group SpA | Stevanato Group SpA | 370,391 | NS | 0.0627% |
| ABUS | Arbutus Biopharma Corp. | 1,119,437 | NS | 0.062017% |
| SEPN | Septerna, Inc. | 200,845 | NS | 0.059418% |
| ANRO | Alto Neuroscience, Inc. | 212,677 | NS | 0.05886% |
| BCAX | Bicara Therapeutics, Inc. | 236,865 | NS | 0.058001% |
| GHRS | GH Research plc | 334,162 | NS | 0.057842% |
| AVBP | ArriVent Biopharma, Inc. | 201,242 | NS | 0.057157% |
| CTMX | CytomX Therapeutics, Inc. | 987,397 | NS | 0.057134% |
| CGEM | Cullinan Therapeutics, Inc. | 323,429 | NS | 0.056582% |
| REPL | Replimune Group, Inc. | 570,930 | NS | 0.053771% |
| PGEN | Precigen, Inc. | 1,104,713 | NS | 0.052633% |
| ARVN | Arvinas, Inc. | 403,100 | NS | 0.052604% |
| SVRA | Savara, Inc. | 775,563 | NS | 0.052133% |
| IRWD | Ironwood Pharmaceuticals, Inc. | 1,173,471 | NS | 0.050709% |
| PHAT | Phathom Pharmaceuticals, Inc. | 356,945 | NS | 0.048822% |
| ZVRA | Zevra Therapeutics, Inc. | 413,742 | NS | 0.047473% |
| CTKB | Cytek Biosciences, Inc. | 868,726 | NS | 0.046738% |
| MGTX | MeiraGTx Holdings plc | 430,643 | NS | 0.045913% |
| SPRY | ARS Pharmaceuticals, Inc. | 463,404 | NS | 0.045812% |
| BIOA | BioAge Labs, Inc. | 211,362 | NS | 0.045511% |
| SANA | Sana Biotechnology, Inc. | 1,235,916 | NS | 0.043821% |
| RIGL | Rigel Pharmaceuticals, Inc. | 131,031 | NS | 0.04362% |
| ZBIO | Zenas Biopharma, Inc. | 175,941 | NS | 0.042346% |
| CMPS | Compass Pathways plc | 612,150 | NS | 0.041676% |
| FULC | Fulcrum Therapeutics, Inc. | 429,371 | NS | 0.040544% |
| OPK | OPKO Health, Inc. | 2,882,600 | NS | 0.040457% |
| SLDB | Solid Biosciences, Inc. | 446,552 | NS | 0.039583% |
| FDMT | 4D Molecular Therapeutics, Inc. | 338,744 | NS | 0.038826% |
| Prothena Corp. plc | Prothena Corp. plc | 323,349 | NS | 0.038694% |
| EBS | Emergent BioSolutions, Inc. | 376,503 | NS | 0.038472% |
| MYGN | Myriad Genetics, Inc. | 662,895 | NS | 0.036725% |
| ABSI | Absci Corp. | 975,088 | NS | 0.036014% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 324,513 | NS | 0.035757% |
| CATX | Perspective Therapeutics, Inc. | 693,460 | NS | 0.035601% |
| ACRS | Aclaris Therapeutics, Inc. | 766,012 | NS | 0.035365% |
| ALT | Altimmune, Inc. | 926,610 | NS | 0.035136% |
| VNDA | Vanda Pharmaceuticals, Inc. | 405,038 | NS | 0.034457% |
| ALLO | Allogene Therapeutics, Inc. | 1,145,572 | NS | 0.034412% |
| RGNX | REGENXBIO, Inc. | 331,423 | NS | 0.034192% |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | 752,567 | NS | 0.033169% |
| PACB | Pacific Biosciences of California, Inc. | 2,021,533 | NS | 0.032852% |
| LXEO | Lexeo Therapeutics, Inc. | 457,447 | NS | 0.032326% |
| Alvotech SA | Alvotech SA | 763,481 | NS | 0.03224% |
| CTNM | Contineum Therapeutics, Inc. | 200,362 | NS | 0.032215% |
| ENTA | Enanta Pharmaceuticals, Inc. | 205,184 | NS | 0.031904% |
| LCTX | Lineage Cell Therapeutics, Inc. | 1,621,430 | NS | 0.03154% |
| LAB | Standard BioTools, Inc. | 2,747,556 | NS | 0.031096% |
| ADCT | ADC Therapeutics SA | 673,142 | NS | 0.031077% |
| DSGN | Design Therapeutics, Inc. | 235,859 | NS | 0.030896% |
| PSNL | Personalis, Inc. | 393,153 | NS | 0.030832% |
SEC N-PORT snapshot as of .